Researchers evaluated the occurrence of adverse events following COVID-19 vaccination with mRNA- and vector-based vaccines, inactivated vaccines, DNA vaccines, and protein subunit vaccines.
Investigators examined patient-reported dyspnea in submaximal exercise in patients with systolic heart failure treated with interleukin-1 blockade.
Researchers investigated the relationship between eosinophilic esophagitis at the time of diagnosis and disease severity, and the change in disease before and after treatment.
Can eicosapentaenoic acid affect the inflammatory response to air pollution particulate in endothelial cells so as to offer a cardiovascular benefit?
A recent update of IPF clinical practice guideline addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases other than IPF.
Researchers assessed the effects of oseltamavir treatment among patients hospitalized with COVID-19 infection.
The American College of Cardiology has published guidelines for managing adult patients with cardiovascular sequelae after COVID-19 infection.
Investigators conducted a cohort study to identify the risk of diabetes following the acute phase of COVID-19 infection.
Researchers examined the relationship between pulmonary artery pulsatility index and multiple adverse outcomes in patients at risk for cardiovascular disease.
Authors of a systematic review report on the impact of race and/or skin tone on the effectiveness of consumer wearable technology to measure heart rate and rhythm.
